Breakfast Activity/Non-CE-Accredited Satellite Symposium: A first in-class NME in 3L+ follicular lymphoma & A Fixed-Duration Treatment Option for 3L+ Diffuse Large B-Cell Lymphoma <br> Genentech </br> <br><i>Seating available on first-come, first-served basis </br></i>